Bio-AMD ^Companies

Bio-AMD has three PoC technologies in development, each using a technology platform to be applied into specific market segments more. Their coagulation technology is in the feasibility stage of commercialization in conjunction with a global hematology major more, in line with our business model that avoids the costs and risks of “go-it-alone” development . The PoC market is growing fast. Forecasters suggest 10% growth per annum over the next few years will make the total market global worth over $22 billion.